

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding NRF2 as a... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2138/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2138" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate.">
            <meta name="og:description" content="Read the latest article version by Takumi Satoh, Stuart Lipton, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13106">
            <meta name="article-id" content="12111">
            <meta name="dc.title" content="Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate">
            <meta name="dc.description" content="Dimethyl fumarate (DMF) is an electrophilic compound previously called BG-12 and marketed under the name Tecfidera &amp;reg; . It was approved in 2013 by the US Food and Drug Administration and the European Medicines Agency for the treatment of relapsing multiple sclerosis. One mechanism of action of DMF is stimulation of the nuclear factor erythroid 2-related factor 2 (NRF2) transcriptional pathway that induces anti-oxidant and anti-inflammatory phase II enzymes to prevent chronic neurodegeneration. However, electrophiles such as DMF also produce severe systemic side effects, in part due to non-specific S-alkylation of cysteine thiols and resulting depletion of glutathione. This mini-review presents the present status and future strategy for NRF2 activators designed to avoid these side effects. Two modes of chemical reaction leading to NRF2 activation are considered here. The first mode is S-alkylation (covalent reaction) of thiols in Kelch-like ECH-associated protein 1 (KEAP1), which interacts with NRF2. The second mechanism involves non-covalent pharmacological inhibition of protein-protein interactions, in particular domain-specific interaction between NRF2 and KEAP1 or other repressor proteins involved in this transcriptional pathway. There have been significant advances in drug development using both of these mechanisms that can potentially avoid the systemic side effects of electrophilic compounds. In the first case concerning covalent reaction with KEAP1, monomethyl fumarate and monoethyl fumarate appear to represent safer derivatives of DMF. In a second approach, pro-electrophilic drugs, such as carnosic acid from the herb Rosmarinus officinalis , can be used as a safe pro-drug of an electrophilic compound. Concerning non-covalent activation of NRF2, drugs are being developed that interfere with the direct interaction of KEAP1-NRF2 or inhibit BTB domain and CNC homolog 1 (BACH1), which is a transcriptional repressor of the promoter where NRF2 binds.">
            <meta name="dc.subject" content="Nrf2, Dimethyl Fumarate, Electrophilic Drugs, KEAP1">
            <meta name="dc.creator" content="Satoh, Takumi">
            <meta name="dc.creator" content="Lipton, Stuart">
            <meta name="dc.date" content="2017/12/14">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12111.1">
            <meta name="dc.source" content="F1000Research 2017 6:2138">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Nrf2">
            <meta name="prism.keyword" content="Dimethyl Fumarate">
            <meta name="prism.keyword" content="Electrophilic Drugs">
            <meta name="prism.keyword" content="KEAP1">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/12/14">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2138">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12111.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2138">
            <meta name="citation_title" content="Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate">
            <meta name="citation_abstract" content="Dimethyl fumarate (DMF) is an electrophilic compound previously called BG-12 and marketed under the name Tecfidera &amp;reg; . It was approved in 2013 by the US Food and Drug Administration and the European Medicines Agency for the treatment of relapsing multiple sclerosis. One mechanism of action of DMF is stimulation of the nuclear factor erythroid 2-related factor 2 (NRF2) transcriptional pathway that induces anti-oxidant and anti-inflammatory phase II enzymes to prevent chronic neurodegeneration. However, electrophiles such as DMF also produce severe systemic side effects, in part due to non-specific S-alkylation of cysteine thiols and resulting depletion of glutathione. This mini-review presents the present status and future strategy for NRF2 activators designed to avoid these side effects. Two modes of chemical reaction leading to NRF2 activation are considered here. The first mode is S-alkylation (covalent reaction) of thiols in Kelch-like ECH-associated protein 1 (KEAP1), which interacts with NRF2. The second mechanism involves non-covalent pharmacological inhibition of protein-protein interactions, in particular domain-specific interaction between NRF2 and KEAP1 or other repressor proteins involved in this transcriptional pathway. There have been significant advances in drug development using both of these mechanisms that can potentially avoid the systemic side effects of electrophilic compounds. In the first case concerning covalent reaction with KEAP1, monomethyl fumarate and monoethyl fumarate appear to represent safer derivatives of DMF. In a second approach, pro-electrophilic drugs, such as carnosic acid from the herb Rosmarinus officinalis , can be used as a safe pro-drug of an electrophilic compound. Concerning non-covalent activation of NRF2, drugs are being developed that interfere with the direct interaction of KEAP1-NRF2 or inhibit BTB domain and CNC homolog 1 (BACH1), which is a transcriptional repressor of the promoter where NRF2 binds.">
            <meta name="citation_description" content="Dimethyl fumarate (DMF) is an electrophilic compound previously called BG-12 and marketed under the name Tecfidera &amp;reg; . It was approved in 2013 by the US Food and Drug Administration and the European Medicines Agency for the treatment of relapsing multiple sclerosis. One mechanism of action of DMF is stimulation of the nuclear factor erythroid 2-related factor 2 (NRF2) transcriptional pathway that induces anti-oxidant and anti-inflammatory phase II enzymes to prevent chronic neurodegeneration. However, electrophiles such as DMF also produce severe systemic side effects, in part due to non-specific S-alkylation of cysteine thiols and resulting depletion of glutathione. This mini-review presents the present status and future strategy for NRF2 activators designed to avoid these side effects. Two modes of chemical reaction leading to NRF2 activation are considered here. The first mode is S-alkylation (covalent reaction) of thiols in Kelch-like ECH-associated protein 1 (KEAP1), which interacts with NRF2. The second mechanism involves non-covalent pharmacological inhibition of protein-protein interactions, in particular domain-specific interaction between NRF2 and KEAP1 or other repressor proteins involved in this transcriptional pathway. There have been significant advances in drug development using both of these mechanisms that can potentially avoid the systemic side effects of electrophilic compounds. In the first case concerning covalent reaction with KEAP1, monomethyl fumarate and monoethyl fumarate appear to represent safer derivatives of DMF. In a second approach, pro-electrophilic drugs, such as carnosic acid from the herb Rosmarinus officinalis , can be used as a safe pro-drug of an electrophilic compound. Concerning non-covalent activation of NRF2, drugs are being developed that interfere with the direct interaction of KEAP1-NRF2 or inhibit BTB domain and CNC homolog 1 (BACH1), which is a transcriptional repressor of the promoter where NRF2 binds.">
            <meta name="citation_keywords" content="Nrf2, Dimethyl Fumarate, Electrophilic Drugs, KEAP1">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Takumi Satoh">
            <meta name="citation_author_institution" content="Department of Anti-Aging Food Research, School of Bioscience and Biotechnology, Tokyo University of Technology, Tokyo, Japan">
            <meta name="citation_author" content="Stuart Lipton">
            <meta name="citation_author_institution" content="Department of Neurosciences, University of California, School of Medicine, La Jolla, CA, USA">
            <meta name="citation_author_institution" content="Neurodegenerative Disease Center, Scintillon Institute, San Diego, CA, USA">
            <meta name="citation_author_institution" content="Neuroscience Translational Center and Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA">
            <meta name="citation_publication_date" content="2017/12/14">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2138">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12111.1">
            <meta name="citation_firstpage" content="2138">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2138/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2138.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13106 /> <input type=hidden id=articleId name=articleId value=12111 /> <input type=hidden id=xmlUrl value="/articles/6-2138/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2138-v1.xml"> <input type=hidden id=article_uuid value=032db233-2803-4411-b21d-2a140b03fb31 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12111.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12111.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2138"
  },
  "headline": "Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent...",
  "datePublished": "2017-12-14T14:54:05",
  "dateModified": "2017-12-14T14:54:05",
  "author": [
    {
      "@type": "Person",
      "name": "Takumi Satoh"
    },    {
      "@type": "Person",
      "name": "Stuart Lipton"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Dimethyl fumarate (DMF) is an electrophilic compound previously called BG-12 and marketed under the name Tecfidera&amp;reg;. It was approved in 2013 by the US Food and Drug Administration and the European Medicines Agency for the treatment of relapsing multiple sclerosis. One mechanism of action of DMF is stimulation of the nuclear factor erythroid 2-related factor 2 (NRF2) transcriptional pathway that induces anti-oxidant and anti-inflammatory phase II enzymes to prevent chronic neurodegeneration. However, electrophiles such as DMF also produce severe systemic side effects, in part due to non-specific S-alkylation of cysteine thiols and resulting depletion of glutathione. This mini-review presents the present status and future strategy for NRF2 activators designed to avoid these side effects. Two modes of chemical reaction leading to NRF2 activation are considered here. The first mode is S-alkylation (covalent reaction) of thiols in Kelch-like ECH-associated protein 1 (KEAP1), which interacts with NRF2. The second mechanism involves non-covalent pharmacological inhibition of protein-protein interactions, in particular domain-specific interaction between NRF2 and KEAP1 or other repressor proteins involved in this transcriptional pathway. There have been significant advances in drug development using both of these mechanisms that can potentially avoid the systemic side effects of electrophilic compounds. In the first case concerning covalent reaction with KEAP1, monomethyl fumarate and monoethyl fumarate appear to represent safer derivatives of DMF. In a second approach, pro-electrophilic drugs, such as carnosic acid from the herb Rosmarinus officinalis, can be used as a safe pro-drug of an electrophilic compound. Concerning non-covalent activation of NRF2, drugs are being developed that interfere with the direct interaction of KEAP1-NRF2 or inhibit BTB domain and CNC homolog 1 (BACH1), which is a transcriptional repressor of the promoter where NRF2 binds."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2138/v1",
            "name": "Recent advances in understanding NRF2 as a druggable target: development..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding NRF2 as a druggable target: development... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13106 data-id=12111 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12111.1" data-recommended="" data-doi="10.12688/f1000research.12111.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2138/v1/pdf?article_uuid=032db233-2803-4411-b21d-2a140b03fb31" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12111-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12111-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12111-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Satoh T and Lipton S. Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2138 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12111.1" target=_blank>https://doi.org/10.12688/f1000research.12111.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12111-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12111 id=track-article-signin-12111 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12111?target=/articles/6-2138/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13106 /> <input name=articleId type=hidden value=12111 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Takumi Satoh<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:slipton@ucsd.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Stuart Lipton</span></a><a href="https://orcid.org/0000-0002-3490-1259" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3490-1259</div><sup>2-4</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Takumi Satoh<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:slipton@ucsd.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Stuart Lipton</span></a><a href="http://orcid.org/0000-0002-3490-1259" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3490-1259</div><sup>2-4</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 14 Dec 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12111.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Anti-Aging Food Research, School of Bioscience and Biotechnology, Tokyo University of Technology, Tokyo, Japan<br/> <sup>2</sup> Neuroscience Translational Center and Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA<br/> <sup>3</sup> Neurodegenerative Disease Center, Scintillon Institute, San Diego, CA, USA<br/> <sup>4</sup> Department of Neurosciences, University of California, School of Medicine, La Jolla, CA, USA<br/> <p> <div class=margin-bottom> Takumi Satoh <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Review & Editing </div> <div class=margin-bottom> Stuart Lipton <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Original Draft Preparation </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28156-28103></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28157-28104></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Dimethyl fumarate (DMF) is an electrophilic compound previously called BG-12 and marketed under the name Tecfidera<sup>&reg;</sup>. It was approved in 2013 by the US Food and Drug Administration and the European Medicines Agency for the treatment of relapsing multiple sclerosis. One mechanism of action of DMF is stimulation of the nuclear factor erythroid 2-related factor 2 (NRF2) transcriptional pathway that induces anti-oxidant and anti-inflammatory phase II enzymes to prevent chronic neurodegeneration. However, electrophiles such as DMF also produce severe systemic side effects, in part due to non-specific S-alkylation of cysteine thiols and resulting depletion of glutathione. This mini-review presents the present status and future strategy for NRF2 activators designed to avoid these side effects. Two modes of chemical reaction leading to NRF2 activation are considered here. The first mode is S-alkylation (covalent reaction) of thiols in Kelch-like ECH-associated protein 1 (KEAP1), which interacts with NRF2. The second mechanism involves non-covalent pharmacological inhibition of protein-protein interactions, in particular domain-specific interaction between NRF2 and KEAP1 or other repressor proteins involved in this transcriptional pathway. There have been significant advances in drug development using both of these mechanisms that can potentially avoid the systemic side effects of electrophilic compounds. In the first case concerning covalent reaction with KEAP1, monomethyl fumarate and monoethyl fumarate appear to represent safer derivatives of DMF. In a second approach, pro-electrophilic drugs, such as carnosic acid from the herb <i>Rosmarinus officinalis</i>, can be used as a safe pro-drug of an electrophilic compound. Concerning non-covalent activation of NRF2, drugs are being developed that interfere with the direct interaction of KEAP1-NRF2 or inhibit BTB domain and CNC homolog 1 (BACH1), which is a transcriptional repressor of the promoter where NRF2 binds. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Nrf2, Dimethyl Fumarate, Electrophilic Drugs, KEAP1 </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Stuart Lipton (<a href="mailto:slipton@ucsd.edu">slipton@ucsd.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Stuart Lipton </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors disclose that their academic institutions have filed patents for PED activators of NRF2 for cell protection in various maladies. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The work was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (25350985 to TS). Additional support was provided by National Institutes of Health grants P01 HD29587, DP1 DA041722, R01 NS086890, RF1 AG 057409, R01 AG056259, and National Institute of Neurological Disease and Stroke Core grant P30 NS076411 (to SAL). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Satoh T and Lipton S. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Satoh T and Lipton S. Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2138 (<a href="https://doi.org/10.12688/f1000research.12111.1" target=_blank>https://doi.org/10.12688/f1000research.12111.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 14 Dec 2017, <b>6</b>(F1000 Faculty Rev):2138 (<a href="https://doi.org/10.12688/f1000research.12111.1" target=_blank>https://doi.org/10.12688/f1000research.12111.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 14 Dec 2017, <b>6</b>(F1000 Faculty Rev):2138 (<a href="https://doi.org/10.12688/f1000research.12111.1" target=_blank>https://doi.org/10.12688/f1000research.12111.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d8895e190>The KEAP1/NRF2 pathway</h2><p class="" id=d8895e193>Neurons are highly sensitive to the balance system between oxidation and reduction, and the disruption of this system can lead to inflammatory reactions contributing to various acute and chronic diseases as well as to the normal aging process<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. Activation of the KEAP1/NRF2/anti-oxidant-response element (ARE) pathway by electrophiles (EPs) can activate this cellular redox defense system against these diseases<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. The NRF2/KEAP1 pathway represents one of the major cellular defense systems against oxidative stress, inflammatory reactions, and exposure to toxic electrophilic compounds<sup><a href="#ref-4">4</a>–<a href="#ref-7">7</a></sup>. NRF2 is a transcription factor that induces various anti-oxidant, anti-inflammatory, and detoxification enzymes<sup><a href="#ref-4">4</a>–<a href="#ref-7">7</a></sup>. Under physiological conditions, KEAP1 protein binds to NRF2 and functions as an adaptor protein for cullin 3 (encoded by <i>Cul3</i> in humans) E3 ubiquitin ligase, which polyubiquitinates NRF2. Consequently, NRF2 is ubiquitinated and degraded by the proteasome<sup><a href="#ref-4">4</a>–<a href="#ref-7">7</a></sup>. Hence, the transcriptional activity of NRF2 is potently inhibited under normal conditions<sup><a href="#ref-4">4</a>–<a href="#ref-7">7</a></sup>.</p><p class="" id=d8895e242>KEAP1 contains critical cysteine thiols that react with endogenous and exogenous EPs<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a>–<a href="#ref-11">11</a></sup>. This reaction reduces the ability of KEAP1 to induce ubiquitination and degradation of NRF2<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a>–<a href="#ref-11">11</a></sup>. After EP reaction, NRF2 dissociates from the cytoplasmic complex with KEAP1, enters the nucleus, and accumulates there to drive transcription of its target phase II genes, which encode a coordinated system of anti-oxidant and anti-inflammatory enzymes. These proteins include enzymes that generate the major cellular anti-oxidant, glutathione (GSH)<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a>–<a href="#ref-11">11</a></sup>. Thus, NRF2 activators have been shown to be anti-inflammatory and neuroprotective at least in part via redox regulation<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a>–<a href="#ref-11">11</a></sup>.</p><p class="" id=d8895e285>Additionally, NRF2 activators can potently induce coordinated expression of genes involved in the autophagy system, including p62<sup><a href="#ref-12">12</a>–<a href="#ref-14">14</a></sup>. In turn, p62 protein then activates the NRF2/ARE pathway, representing a positive feedback loop between the NRF2/ARE pathway and autophagy network<sup><a href="#ref-12">12</a>–<a href="#ref-14">14</a></sup>. By simulating autophagy in this fashion, NRF2 activators can potentially remove misfolded proteins and thus suppress several diseases associated with abnormal protein conformation<sup><a href="#ref-12">12</a>–<a href="#ref-14">14</a></sup>. NRF2 activators have also been suggested to be neuroprotective against Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD)<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a>–<a href="#ref-14">14</a></sup> on the basis of results in animal models of these neurodegenerative disorders.</p><p class="" id=d8895e319>During oxidative stress, p62 expression is enhanced via an NRF2-mediated mechanism. The increased p62 can interfere with NRF2/KEAP1 binding and thus results in a positive feedback loop, increasing NRF2 activation<sup><a href="#ref-12">12</a>–<a href="#ref-14">14</a></sup>. The detailed mechanism of p62-KEAP1-NRF2 interaction remains contentious, but some possible scenarios have been proposed<sup><a href="#ref-13">13</a></sup>. For example, p62 has a STGE motif in its KEAP1-interacting domain and thus p62 may directly bind to KEAP1. The p62 STGE motif may potentially compete with the NRF2 ETGE motif, which is essential for KEAP1-NRF2 interaction<sup><a href="#ref-13">13</a></sup>. When p62 is upregulated by NRF2 under oxidative stress, p62 then may compete out NRF2 from the KEAP1-NRF2 complex, thus allowing NRF2 to translocate into the nucleus and activate the ARE in the promoter region of phase II genes<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d8895e342>However, some NRF2 activators that upregulate p62, such as arsenic, may result in impairment of autophagy, and p62 activation of NRF2 often occurs in the setting of autophagy impairment<sup><a href="#ref-13">13</a></sup>. Thus, increased p62 can be associated with impairment of autophagy rather than facilitation<sup><a href="#ref-12">12</a></sup>. Although NRF2 controls the expression of several autophagy-related genes<sup><a href="#ref-14">14</a></sup>, the functional linkage between NRF2 and these putative target autophagy genes under physiological or pathophysiological conditions remains to be determined.</p><p class="" id=d8895e357>NRF2 manifests both positive and negative attributes with respect to cancer and other diseases<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. On the one hand, NRF2 activators have been proposed for the treatment of various forms of cancer<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. In contrast, other recent investigations based on genetic findings suggest that NRF2 activation can promote neoplasia, possibly by enhancing resistance to cancer treatment<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. For example, gain-of-function mutations in NRF2 and loss-of-function mutations in KEAP1 have been encountered in tumors of the digestive tract<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. Further investigation is merited to clarify the biological significance of NRF2 activation in cancer<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8895e401>Cysteine-mediated regulation of KEAP1</h2><p class="" id=d8895e404>Among the cysteine thiols of KEAP1 protein, the most characterized reactive thiols are Cys151, Cys273, and Cys288, and they have differential roles in the activation of the KEAP1/NRF2 pathway. The major cysteine residues of KEAP1 that react with EPs are Cys151, Cys273, and Cys288. Each of these cysteine thiols may differentially regulate phase II anti-oxidant gene expression stimulated by the KEAP1/NRF2 transcriptional pathway<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup>.</p><p class="" id=d8895e414>For example, KEAP1 Cys151 contains the most important thiol for activation of the KEAP1/NRF2 transcriptional pathway<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. Located in the N-terminal BTB domain, Cys151 may be very reactive because of a stretch of basic amino acids in the α5 helical structure<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. One model suggests that covalent modification of Cys151 causes dissociation of the KEAP1/Cullin3 heterodimer, resulting in inhibition of NRF2 ubiquitination<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. Reaction of Cys151 with EPs is thus critical for inhibition of NRF2 degradation mediated by KEAP1-dependent degradation of NRF2<sup><a href="#ref-19">19</a>–<a href="#ref-21">21</a></sup>. In contrast, mutation of KEAP1 Cys151 produces constitutive inhibition of NRF2 under both physiological and pathological conditions in cell-based assays<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>. Additionally, ubiquitination and degradation of NRF2 require cysteine residues 273 and 288 of KEAP1. Previous studies of mutations revealed that substitution of Cys273 or Cys288 prevented KEAP1 from repressing NRF2 activity under homeostatic conditions<sup><a href="#ref-24">24</a>–<a href="#ref-26">26</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8895e463>DMF/MMF/MEF</h2><div class=section><a name=d8895e466 class=n-a></a><h3 class=section-title>Dimethyl fumarate</h3><p class="" id=d8895e471>Dimethyl fumarate (DMF) is currently approved for clinical use by the US Food and Drug Administration (FDA) and the European Medicines Agency for the treatment of relapsing multiple sclerosis (MS)<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>. DMF is an alkylating agent, similar to the classic NRF2 activator sulforaphane, which can non-specifically and covalently modify nucleophilic groups in proteins, including cysteine thiols<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. As a result, serious side effects can occur with this type of drug. For example, a 30% decline in lymphocyte counts has been reported after administration of DMF, which may predispose to infection<sup><a href="#ref-31">31</a>–<a href="#ref-34">34</a></sup>. DMF has two congeners: monomethyl fumarate (MMF) and monoethyl fumarate (MEF). Recent research interest has shifted to MEF and MMF with the hope of developing a safer drug than DMF because both of these congeners are less electrophilic than DMF<sup><a href="#ref-35">35</a>–<a href="#ref-38">38</a></sup>. DMF has also been shown to react with other thiol targets, which appear to predominate over KEAP1, at least in T cells<sup><a href="#ref-39">39</a></sup>.</p></div><div class=section><a name=d8895e507 class=n-a></a><h3 class=section-title>Monoethyl fumarate</h3><p class="" id=d8895e512>DMF and MEF react with disparate KEAP1 thiols, and DMF is more reactive toward a larger number of cysteines<sup><a href="#ref-35">35</a>–<a href="#ref-39">39</a></sup>. MEF appears to solely modulate Cys151 on KEAP1 and manifests significantly less reaction with other KEAP1 cysteines compared with DMF (<a href="#f1">Figure 1</a>)<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. On the other hand, DMF induces greater NRF2 protein accumulation than MEF<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. Potentially accounting for some of its side effects, DMF has also been shown to acutely deplete GSH in a concentration-dependent manner<sup><a href="#ref-32">32</a>,<a href="#ref-34">34</a>,<a href="#ref-35">35</a>,<a href="#ref-39">39</a></sup>. In contrast, MEF maintains GSH levels and, in fact, may produce an increase, possibly due to NRF2 stimulation of GSH synthetic enzymes<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. Thus, MEF may prove to be less toxic than DMF<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13106/687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure1.gif"><img alt="687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13106/687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure1.gif"></a><div class=caption><h3>Figure 1. DMF and MEF modulate distinctive repertoires of cysteine thiols on KEAP1.</h3><p id=d8895e577>Although DMF reacts with many cysteine residues, including Cys151, Cys273, and Cys288, MEF appears to react preferentially with Cys151. DMF has proven to be more toxic than MEF, although DMF and MEF both activate NRF2, at least <i>in vitro</i><sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. DMF, dimethyl fumarate; KEAP1, Kelch-like ECH-associated protein 1; MEF, monoethylfumarate; NRF2, nuclear factor erythroid 2-related factor 2.</p></div></div></div><div class=section><a name=d8895e594 class=n-a></a><h3 class=section-title>Monomethyl fumarate</h3><p class="" id=d8895e599>A recent study demonstrates similar therapeutic benefits for DMF and its bioactive metabolite MMF in a rat model of PD and brain stroke<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. Despite their similar pharmacological effects <i>in vivo</i>, MMF is a less potent NRF2 activator and manifests less toxicity <i>in vitro</i>, probably because it manifests orders of magnitude less non-specific alkylating capacity than DMF (<a href="#f2">Figure 2</a>)<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. The discovery of the therapeutic effects of MMF in an experimental PD model without substantial non-specific alkylating properties compared with DMF suggests that MMF may be a candidate for PD and stroke therapeutics<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. MEF may also potentially be considered as a therapeutic agent since its alkylating capacity is also low like that of MMF<sup><a href="#ref-35">35</a>–<a href="#ref-38">38</a></sup>. Nonetheless, the lack of specificity of these alkylating NRF2 activators with regard to other protein thiol targets as well as further consideration of their pharmacokinetic and pharmacodynamic properties may limit their ultimate usefulness<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13106/687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure2.gif"><img alt="687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13106/687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure2.gif"></a><div class=caption><h3>Figure 2. Discrepancy between <i>in vivo</i> and <i>in vitro</i> actions of DMF and MMF in murine PD models.</h3><p id=d8895e663>DMF and MMF show comparable protective action in an <i>in vivo</i> rodent model of PD. In contrast, MMF is far less potent than DMF in terms of <i>in vitro</i> NRF2 activation<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. There are at least two possible explanations for this discrepancy. One possible interpretation is that DMF and MMF display differential ADME/T (absorption, distribution, metabolism, excretion, toxicity) parameters <i>in vivo</i><sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. Another possible explanation is that reaction with HCAR2 or another target mediates the protective effects by DMF<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. DMF, dimethyl fumarate; HCAR2, hydroxycarboxylic acid receptor 2; MMF, monomethylfumarate; NRF2, nuclear factor erythroid 2-related factor 2; PD, Parkinson’s disease.</p></div></div></div><div class=section><a name=d8895e700 class=n-a></a><h3 class=section-title>Hydroxycarboxylic acid receptor 2 as an alternate target</h3><p class="" id=d8895e705>Other experiments suggest that HCAR2 activation, rather than NRF2 activation, may be partially responsible for the beneficial action of DMF and MMF in PD and MS models<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. HCAR2 is a G protein–coupled receptor whose ligands are hydroxyl-carboxylic acids produced from energy metabolism in order to sense cellular metabolic status<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. HCAR2 is expressed in a number of immune cells and other cell types<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. Emerging evidence suggests that HCAR2 exerts potentially therapeutic anti-inflammatory actions<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. Along these lines, in <i>Hcar2</i><sup>-/-</sup> mice, the beneficial effect of DMF in a mouse model of MS (autoimmune encephalomyelitis or experimental autoimmune encephalomyelitis) is completely abrogated, consistent with the notion that HCAR2 plays an important role in the effect of DMF<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. Anti-inflammatory effects of DMF in the brain have also been posited to be NRF2-dependent, at least in part<sup><a href="#ref-42">42</a></sup>. If HCAR2 is indeed a major therapeutic target of DMF in AD, PD, and HD, then the ketone body ß-hydroxybutyrate, a known HCAR2 ligand, may prove to be a more suitable therapeutic than DMF, MEF, or MMF<sup><a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>. Hence, additional thiol targets of DMF and related compounds are a major focus of current studies.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8895e764>Pro-electrophilic drugs as pathologically activated therapeutic drugs</h2><div class=section><a name=d8895e767 class=n-a></a><h3 class=section-title>Pro-electrophilic drugs</h3><p class="" id=d8895e772>Redox imbalance (for example, excessive oxidation over reduction) is believed to contribute to a variety of diseases<sup><a href="#ref-1">1</a></sup>. Prior use of EPs to improve redox balance by activating transcriptional systems against oxidative stress has been met with mixed success, largely because of side effects due to the indiscriminate action of EPs<sup><a href="#ref-2">2</a></sup>. A newer approach uses pro-drug forms of EPs, known as pro-electrophilic drugs (PEDs), such as carnosic acid (CA), an active ingredient in the herb rosemary (<i>Rosmarinus officinalis</i>)<sup><a href="#ref-45">45</a>–<a href="#ref-50">50</a></sup>. Additional compounds of interest include zonarol (ZO) and isozonarol (IZ), which are found in seaweed (<i>Dictyopteris undulata</i>) (<a href="#f3">Figure 3</a>)<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>, as well as related synthetic chemicals<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>. Importantly, these PEDs do not react directly with cysteine thiols. However, oxidative stress triggers their conversion from hydroquinone to quinone, representing an active EP. The EP then triggers KEAP1/NRF2/ARE transcriptional activity, resulting in the production of anti-oxidant/anti-inflammatory phase II enzymes<sup><a href="#ref-45">45</a>,<a href="#ref-49">49</a></sup>.</p><div class="fig panel clearfix"><a name=f3 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13106/687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure3.gif"><img alt="687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13106/687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure3.gif"></a><div class=caption><h3>Figure 3. Activation of the KEAP1/NRF2 pathway by PEDs (PED 1, CA; PED 2, ZO).</h3><p id=d8895e831>The PED compounds CA (with adjacent or “<i>ortho</i>-” position hydroxyl groups)<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a>,<a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup> and ZO (with hydroxyl groups located directly across the ring, in the “<i>para</i>-” position)<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup> become oxidized to the electrophilic <i>quinone</i> form. CA and ZO quinones undergo nucleophilic attack by a critical KEAP1 cysteine thiol. The reaction forms a KEAP1-CA or KEAP1-ZO adduct. This results in release of NRF2 from KEAP1/NRF2 complexes, accumulation of NRF2 in the nucleus, and subsequent transcriptional activation of phase II enzymes<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>. Phase II anti-oxidant and anti-inflammatory enzymes reduce reactive oxygen species and thus improve the resilience of neurons. Importantly, the oxidation of hydroquinone (PED) to quinone (EP) is triggered by oxidative stress, which is then combatted by this transcriptional activity, as described in the text<sup><a href="#ref-45">45</a>,<a href="#ref-49">49</a></sup>. CA, carnosic acid; EP, electrophile; KEAP1, Kelch-like ECH-associated protein 1; NRF2, nuclear factor erythroid 2-related factor 2; PD, Parkinson’s disease; PED, pro-electrophilic drug; ZO, zonarol.</p></div></div><p class="" id=d8895e882>The combined efforts of the authors’ research groups have led to the development of PEDs that are activated by the very oxidative stress that they then serve to counteract. This type of action has been deemed a pathologically activated therapeutic or ‘PAT’ drug<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>—a drug that is active only at the site where it is needed and thus represents a gentle tap or pat compared with more indiscriminant reagents that are reactive throughout the body, such as more conventional EPs<sup><a href="#ref-45">45</a>,<a href="#ref-49">49</a></sup>. Since PEDs are not activated in normal cells, they do not indiscriminately react with other thiols such as GSH; moreover, the cells undergoing oxidative stress in which PEDs are converted to EPs already display depleted levels of GSH; hence, the EP generated from the PED does not encounter the normally high levels of GSH with which to react<sup><a href="#ref-45">45</a>,<a href="#ref-49">49</a></sup>. This type of action may help to minimize the side effects of PEDs while retaining beneficial activity<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup>. Thus, the anti-oxidant NRF2-activating therapy of PEDs is targeted only to cells ‘in need’. Additionally, owing to their stimulation of a transcriptional pathway producing endogenous anti-oxidant enzymes, PEDs exhibit a more sustained and amplified action than standard anti-oxidant compounds<sup><a href="#ref-45">45</a>,<a href="#ref-48">48</a></sup>. Accordingly, our recent neurobehavioral and histological readouts suggest that CA, acting as a PED, and administered orally, transnasally, or parenterally <i>in vivo</i>, can be an effective treatment for AD and other neurologic conditions in rodent models<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a>,<a href="#ref-50">50</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8895e938>Inhibitors of protein-protein interaction</h2><div class=section><a name=d8895e941 class=n-a></a><h3 class=section-title>KEAP1-NRF2 PPI</h3><p class="" id=d8895e946>NRF2 has a Neh2 domain in its N-terminal regulatory region, which is important for binding to the Kelch-DC domain of the C-terminus of KEAP1<sup><a href="#ref-17">17</a>–<a href="#ref-20">20</a></sup>. Peptides capable of blocking the KEAP1-NRF2 protein-protein interaction (PPI) have been identified and proven to be protective in models of global ischemia<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. Importantly, this non-covalent mechanism of action is completely different from electrophilic NRF2 activators, which react at Cys151 of the N-terminal domain of KEAP1 in a covalent manner<sup><a href="#ref-17">17</a>–<a href="#ref-20">20</a></sup>. Recent structural and functional studies have further illuminated the details of the non-canonical mechanism of NRF2 activation<sup><a href="#ref-17">17</a>–<a href="#ref-20">20</a></sup>. The Kelch-DC domain of KEAP1 binds to NRF2 via either its DLG or ETGE motif; both of these motifs are thought to be the major targets of non-covalent inhibitors of KEAP1-NRF2 PPI<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. In a hinge-and-latch model of this interaction, the ETGE motif has a higher affinity for KEAP1 than the DLG motif, which causes the latter to associate and dissociate from KEAP1 in a dynamic manner, resulting in oscillations between a ‘closed’ (associated) and ‘open’ (dissociated) conformation<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>.</p></div><div class=section><a name=d8895e993 class=n-a></a><h3 class=section-title>KEAP1-NRF2 PPI inhibitors</h3><p class="" id=d8895e998>Non-electrophilic NRF2 activators have been proposed as therapeutic agents for chronic neurodegeneration and inflammation because of their potentially lower incidence of side effects compared with EPs (<a href="#f4">Figure 4</a>)<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. Using peptide displacement for high-throughput screening, small molecules have been identified that interfere with KEAP1-NRF2 binding<sup><a href="#ref-57">57</a>–<a href="#ref-60">60</a></sup>. Accordingly, KEAP1-NRF2 PPI inhibitors are being studied as NRF2 activators in several disease models<sup><a href="#ref-6">6</a>,<a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>. Taking advantage of this molecular mechanism of action should allow chemists to optimize such agents for the development of non-covalent NRF2 activators<sup><a href="#ref-63">63</a>–<a href="#ref-67">67</a></sup>. To date, many studies of KEAP1-NRF2 PPI inhibitors have focused on the KEAP1-NRF2 ETGE motif<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. However, the affinity of this binding reaction is very high and difficult to inhibit<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. In contrast, as alluded to above, the KEAP1-NRF2 DLG interaction is weaker and has rapid association and dissociation rates<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. Thus, inhibition of binding at the KEAP1-NRF2 DLG may represent an improved approach to further develop effective KEAP1-NRF2 PPI inhibitors<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. Another possible target is the p62 STGE motif, which can compete with the NRF2 ETGE motif for binding to KEAP1<sup><a href="#ref-12">12</a>–<a href="#ref-14">14</a></sup>.</p><div class="fig panel clearfix"><a name=f4 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13106/687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure4.gif"><img alt="687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure4.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13106/687c83c8-9d1d-45cd-9a3c-61cd36f96883_figure4.gif"></a><div class=caption><h3>Figure 4. Two types of PPI inhibitors can activate NRF2.</h3><p id=d8895e1081>NRF2-KEAP1 PPI inhibitors directly inhibit binding of NRF2 and KEAP1 proteins and result in NRF2 release, translocation into the nucleus, and activation of phase II gene transcription<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. Under physiological conditions, BACH1 constitutively inhibits NRF2-mediated transcriptional activity<sup><a href="#ref-68">68</a>–<a href="#ref-71">71</a></sup>. BACH1 inhibitors bind to BACH1<sup><a href="#ref-68">68</a>–<a href="#ref-71">71</a></sup>. Thus, BACH1 inhibitors can activate transcription of NRF2-dependent phase II genes<sup><a href="#ref-74">74</a></sup>. In this figure, the “X” designates a partner of sMAFs<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. X and sMAFs can form homo- or hetero-dimers and bind to ARE elements<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. When “X” is a sMAF or BACH1, phase II enzymes are not induced; in contrast, when “X” is NRF2, phase II enzymes are induced<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. ARE, anti-oxidant-response element; BACH1, BTB and CNC homology 1; KEAP1, Kelch-like ECH-associated protein 1; NRF2, nuclear factor erythroid 2-related factor 2; PPI, protein-protein interaction; sMAF, small musculoaponeurotic fibrosarcoma protein.</p></div></div></div><div class=section><a name=d8895e1136 class=n-a></a><h3 class=section-title>BTB and CNC homology 1 inhibitors</h3><p class="" id=d8895e1141>Yet another mechanism for ARE-mediated gene regulation involves BACH1, which functions as an inhibitor of NRF2-mediated transcription by binding to small musculoaponeurotic fibrosarcoma proteins (sMAFs) and occupying ARE promoter elements<sup><a href="#ref-68">68</a>–<a href="#ref-71">71</a></sup>. As shown in <a href="#f4">Figure 4</a>, the basic concept of BACH1 inhibition is competition between BACH1 and NRF2 for dimer formation with sMAFs on ARE-containing promoters<sup><a href="#ref-68">68</a>–<a href="#ref-71">71</a></sup>. In essence, BACH1 inhibitors serve to inhibit the action of an inhibitor, resulting in NRF2 activation. sMAFs are leucine zipper–type transcription factors containing basic regions<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. The basic region of sMAF family members contributes to the distinct DNA-binding mode of this class of proteins<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. sMAFs form homodimers as well as heterodimers with NRF2 or BACH1<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. Because NRF2 and BACH1 cannot bind to DNA as monomers, sMAFs are indispensable partners in order to bind to ARE-containing promotors. In contrast, sMAF homodimers basically act as transcriptional repressors<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. Additionally, binding of heme to BACH1 will displace this repressor, allowing it to be degraded<sup><a href="#ref-68">68</a>–<a href="#ref-71">71</a></sup>. As expected, BACH1 gene knockout results in activation of the KEAP1/NRF2 pathway and protection in various disease models<sup><a href="#ref-68">68</a>–<a href="#ref-71">71</a></sup>. Hence, the development of drugs that bind BACH1 could also contribute to activation of NRF2-dependent phase II enzymes and prove therapeutic in the future<sup><a href="#ref-70">70</a>,<a href="#ref-74">74</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8895e1216>Summary</h2><p class="" id=d8895e1219>In conclusion, new forms of both covalent and non-covalent NRF2 activators have recently shown promise as protectants from neurologic diseases; they may also be beneficial for other cell types affected in systemic diseases, including type 2 diabetes mellitus and possibly even normal aging. The new compounds offer hope of efficacy without indiscriminately reacting with protein thiols, which contribute to the multiple side effects observed with the older EP-like drugs, including curcumin and DMF. Recently, excitement has been generated over the possibility of developing non-covalent NRF2 activators. However, the pathologically targeted covalent-reacting PED, CA, appears on the ‘generally regarded as safe’ (GRAS) list approved by the FDA and has been consumed in large quantities by humans for over two thousand years without incident. It is not yet clear whether the newer non-covalent NRF2 activators will be as well tolerated by humans and avoid systemic toxicity. Considerable further discovery, optimization, and clinical testing will be needed to bring these new drugs to market for neurological as well as systemic diseases.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8895e1225>Abbreviations</h2><p class="" id=d8895e1228>AD, Alzheimer’s disease; ARE, anti-oxidant-response element; BACH1, BTB and CNC homology 1; CA, carnosic acid; DMF, dimethyl fumarate; EP, electrophile; FDA, US Food and Drug Administration; GSH, glutathione; HCAR2, hydroxycarboxylic acid receptor 2; HD, Huntington’s disease; KEAP1, Kelch-like ECH-associated protein 1; MEF, monoethylfumarate; MMF, monomethylfumarate; MS, multiple sclerosis; NRF2, nuclear factor erythroid 2-related factor 2; PD, Parkinson’s disease; PED, pro-electrophilic drug; PPI, protein-protein interaction; sMAF, small musculoaponeurotic fibrosarcoma protein.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d8895e1 class=n-a></a><h2 class=main-title id=d9127>Competing interests</h2><p class=metadata-entry><a name=d8895e115 class=n-a></a><p id=d8895e116> The authors disclose that their academic institutions have filed patents for PED activators of NRF2 for cell protection in various maladies.</p></p></div><div class=back-section><a name=d8895e1 class=n-a></a><h2 class=main-title id=d9129>Grant information</h2><p>This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The work was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (25350985 to TS). Additional support was provided by National Institutes of Health grants P01 HD29587, DP1 DA041722, R01 NS086890, RF1 AG 057409, R01 AG056259, and National Institute of Neurological Disease and Stroke Core grant P30 NS076411 (to SAL).</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d8895e1235 class=n-a></a><h2 class=main-title id=d8895e1237>Acknowledgements</h2><p class="" id=d8895e1240>We thank the members of our laboratories and our esteemed collaborators without whom this work would not have been possible.</p></div><div class=back-section><a name=d8895e1244 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d9414>References</h2><div class="section ref-list"><a name=d8895e1244 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d8895e1251 class=n-a></a>Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. <i>Science.</i> 1993; <b>262</b>(5134): 689–95. <a target=xrefwindow id=d8895e1259 href="http://www.ncbi.nlm.nih.gov/pubmed/7901908">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1262 href="http://dx.doi.org/10.1126/science.7901908">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1053828"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1271 class=n-a></a>Satoh T, Lipton SA: Redox regulation of neuronal survival mediated by electrophilic compounds. <i>Trends Neurosci.</i> 2007; <b>30</b>(1): 37–45. <a target=xrefwindow id=d8895e1279 href="http://www.ncbi.nlm.nih.gov/pubmed/17137643">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1282 href="http://dx.doi.org/10.1016/j.tins.2006.11.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1053828">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d8895e1295 class=n-a></a>Satoh T, Okamoto S, Cui J, <i> et al.</i>: Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. <i>Proc Natl Acad Sci U S A.</i> 2006; <b>103</b>(3): 768–73. <a target=xrefwindow id=d8895e1306 href="http://www.ncbi.nlm.nih.gov/pubmed/16407140">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1309 href="http://dx.doi.org/10.1073/pnas.0505723102">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1313 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1334635">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725601011"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1322 class=n-a></a>Tebay LE, Robertson H, Durant ST, <i> et al.</i>: Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. <i>Free Radic Biol Med.</i> 2015; <b>88</b>(Pt B): 108–46. <a target=xrefwindow id=d8895e1333 href="http://www.ncbi.nlm.nih.gov/pubmed/26122708">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1336 href="http://dx.doi.org/10.1016/j.freeradbiomed.2015.06.021">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1340 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4659505">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725601011">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d8895e1353 class=n-a></a>Joshi G, Johnson JA: The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. <i>Recent Pat CNS Drug Discov.</i> 2012; <b>7</b>(3): 218–29. <a target=xrefwindow id=d8895e1361 href="http://www.ncbi.nlm.nih.gov/pubmed/22742419">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1364 href="http://dx.doi.org/10.2174/157488912803252023">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1367 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3625035">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d8895e1377 class=n-a></a>Magesh S, Chen Y, Hu L: Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. <i>Med Res Rev.</i> 2012; <b>32</b>(4): 687–726. <a target=xrefwindow id=d8895e1385 href="http://www.ncbi.nlm.nih.gov/pubmed/22549716">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1388 href="http://dx.doi.org/10.1002/med.21257">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1391 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3393814">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730131598"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1400 class=n-a></a>Deshmukh P, Unni S, Krishnappa G, <i> et al.</i>: The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. <i>Biophys Rev.</i> 2017; <b>9</b>(1): 41–56. <a target=xrefwindow id=d8895e1411 href="http://www.ncbi.nlm.nih.gov/pubmed/28510041">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1414 href="http://dx.doi.org/10.1007/s12551-016-0244-4">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1418 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5425799">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730131598">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d8895e1431 class=n-a></a>Poillet-Perez L, Despouy G, Delage-Mourroux R, <i> et al.</i>: Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. <i>Redox Biol.</i> 2015; <b>4</b>: 184–92. <a target=xrefwindow id=d8895e1442 href="http://www.ncbi.nlm.nih.gov/pubmed/25590798">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1445 href="http://dx.doi.org/10.1016/j.redox.2014.12.003">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1449 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4803791">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d8895e1458 class=n-a></a>Copple IM, Dinkova-Kostova AT, Kensler TW, <i> et al.</i>: NRF2 as an Emerging Therapeutic Target. <i>Oxid Med Cell Longev.</i> 2017; <b>2017</b>: 8165458. <a target=xrefwindow id=d8895e1469 href="http://www.ncbi.nlm.nih.gov/pubmed/28250892">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1472 href="http://dx.doi.org/10.1155/2017/8165458">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1476 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5306997">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726534862"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1485 class=n-a></a>Huang Y, Li W, Su ZY, <i> et al.</i>: The complexity of the Nrf2 pathway: beyond the antioxidant response. <i>J Nutr Biochem.</i> 2015; <b>26</b>(12): 1401–13. <a target=xrefwindow id=d8895e1496 href="http://www.ncbi.nlm.nih.gov/pubmed/26419687">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1499 href="http://dx.doi.org/10.1016/j.jnutbio.2015.08.001">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1503 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4785809">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726534862">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d8895e1516 class=n-a></a>Senger DR, Li D, Jaminet SC, <i> et al.</i>: Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet. <i>PLoS One.</i> 2016; <b>11</b>(2): e0148042. <a target=xrefwindow id=d8895e1527 href="http://www.ncbi.nlm.nih.gov/pubmed/26885667">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1530 href="http://dx.doi.org/10.1371/journal.pone.0148042">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1534 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4757558">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727653084"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1544 class=n-a></a>Liu WJ, Ye L, Huang WF, <i> et al.</i>: p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. <i>Cell Mol Biol Lett.</i> 2016; <b>21</b>: 29. <a target=xrefwindow id=d8895e1555 href="http://www.ncbi.nlm.nih.gov/pubmed/28536631">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1558 href="http://dx.doi.org/10.1186/s11658-016-0031-z">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1562 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5415757">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727653084">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725597107"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1575 class=n-a></a>Jiang T, Harder B, Rojo de la Vega M, <i> et al.</i>: p62 links autophagy and Nrf2 signaling. <i>Free Radic Biol Med.</i> 2015; <b>88</b>(Pt B): 199–204. <a target=xrefwindow id=d8895e1586 href="http://www.ncbi.nlm.nih.gov/pubmed/26117325">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1589 href="http://dx.doi.org/10.1016/j.freeradbiomed.2015.06.014">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1593 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4628872">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725597107">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727225356"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1606 class=n-a></a>Pajares M, Cuadrado A, Rojo AI: Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases. <i>Redox Biol.</i> 2017; <b>11</b>: 543–53. <a target=xrefwindow id=d8895e1614 href="http://www.ncbi.nlm.nih.gov/pubmed/28104575">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1617 href="http://dx.doi.org/10.1016/j.redox.2017.01.006">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1620 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5239825">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727225356">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d8895e1633 class=n-a></a>Sporn MB, Liby KT: NRF2 and cancer: the good, the bad and the importance of context. <i>Nat Rev Cancer.</i> 2012; <b>12</b>(8): 564–71. <a target=xrefwindow id=d8895e1641 href="http://www.ncbi.nlm.nih.gov/pubmed/22810811">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1644 href="http://dx.doi.org/10.1038/nrc3278">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1647 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3836441">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726404101"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1656 class=n-a></a>Menegon S, Columbano A, Giordano S: The Dual Roles of NRF2 in Cancer. <i>Trends Mol Med.</i> 2016; <b>22</b>(7): 578–93. <a target=xrefwindow id=d8895e1664 href="http://www.ncbi.nlm.nih.gov/pubmed/27263465">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1667 href="http://dx.doi.org/10.1016/j.molmed.2016.05.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726404101">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726620955"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1680 class=n-a></a>Dinkova-Kostova AT, Kostov RV, Canning P: Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants. <i>Arch Biochem Biophys.</i> 2017; <b>617</b>: 84–93. <a target=xrefwindow id=d8895e1688 href="http://www.ncbi.nlm.nih.gov/pubmed/27497696">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1691 href="http://dx.doi.org/10.1016/j.abb.2016.08.005">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1694 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5339396">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726620955">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725906809"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1708 class=n-a></a>Saito R, Suzuki T, Hiramoto K, <i> et al.</i>: Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response. <i>Mol Cell Biol.</i> 2015; <b>36</b>(2): 271–84. <a target=xrefwindow id=d8895e1719 href="http://www.ncbi.nlm.nih.gov/pubmed/26527616">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1722 href="http://dx.doi.org/10.1128/MCB.00868-15">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1726 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4719294">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725906809">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d8895e1739 class=n-a></a>Sekhar KR, Rachakonda G, Freeman ML: Cysteine-based regulation of the CUL3 adaptor protein Keap1. <i>Toxicol Appl Pharmacol.</i> 2010; <b>244</b>(1): 21–6. <a target=xrefwindow id=d8895e1747 href="http://www.ncbi.nlm.nih.gov/pubmed/19560482">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1750 href="http://dx.doi.org/10.1016/j.taap.2009.06.016">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1753 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2837771">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d8895e1762 class=n-a></a>Zhang DD, Lo S, Cross JV, <i> et al.</i>: Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. <i>Mol Cell Biol.</i> 2004; <b>24</b>(24): 10941–53. <a target=xrefwindow id=d8895e1773 href="http://www.ncbi.nlm.nih.gov/pubmed/15572695">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1776 href="http://dx.doi.org/10.1128/MCB.24.24.10941-10953.2004">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1780 href="http://www.ncbi.nlm.nih.gov/pmc/articles/533977">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d8895e1789 class=n-a></a>Dunlap T, Piyankarage SC, Wijewickrama GT, <i> et al.</i>: Quinone-induced activation of Keap1/Nrf2 signaling by aspirin prodrugs masquerading as nitric oxide. <i>Chem Res Toxicol.</i> 2012; <b>25</b>(12): 2725–36. <a target=xrefwindow id=d8895e1800 href="http://www.ncbi.nlm.nih.gov/pubmed/23035985">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1803 href="http://dx.doi.org/10.1021/tx3003609">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1807 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3896098">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d8895e1816 class=n-a></a>Antelmann H, Helmann JD: Thiol-based redox switches and gene regulation. <i>Antioxid Redox Signal.</i> 2011; <b>14</b>(6): 1049–63. <a target=xrefwindow id=d8895e1824 href="http://www.ncbi.nlm.nih.gov/pubmed/20626317">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1827 href="http://dx.doi.org/10.1089/ars.2010.3400">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1830 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3113447">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d8895e1839 class=n-a></a>Shen T, Jiang T, Long M, <i> et al.</i>: A Curcumin Derivative That Inhibits Vinyl Carbamate-Induced Lung Carcinogenesis via Activation of the Nrf2 Protective Response. <i>Antioxid Redox Signal.</i> 2015; <b>23</b>(8): 651–64. <a target=xrefwindow id=d8895e1850 href="http://www.ncbi.nlm.nih.gov/pubmed/25891177">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1853 href="http://dx.doi.org/10.1089/ars.2014.6074">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1857 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4560850">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d8895e1867 class=n-a></a>Takaya K, Suzuki T, Motohashi H, <i> et al.</i>: Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. <i>Free Radic Biol Med.</i> 2012; <b>53</b>(4): 817–27. <a target=xrefwindow id=d8895e1878 href="http://www.ncbi.nlm.nih.gov/pubmed/22732183">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1881 href="http://dx.doi.org/10.1016/j.freeradbiomed.2012.06.023">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1885 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3539416">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d8895e1894 class=n-a></a>He X, Ma Q: Critical cysteine residues of Kelch-like ECH-associated protein 1 in arsenic sensing and suppression of nuclear factor erythroid 2-related factor 2. <i>J Pharmacol Exp Ther.</i> 2010; <b>332</b>(1): 66–75. <a target=xrefwindow id=d8895e1902 href="http://www.ncbi.nlm.nih.gov/pubmed/19808700">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1905 href="http://dx.doi.org/10.1124/jpet.109.160465">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1908 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2802466">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d8895e1917 class=n-a></a>Yamamoto T, Suzuki T, Kobayashi A, <i> et al.</i>: Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. <i>Mol Cell Biol.</i> 2008; <b>28</b>(8): 2758–70. <a target=xrefwindow id=d8895e1928 href="http://www.ncbi.nlm.nih.gov/pubmed/18268004">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1931 href="http://dx.doi.org/10.1128/MCB.01704-07">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2293100">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d8895e1944 class=n-a></a>Prosperini L, Pontecorvo S: Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations. <i>Ther Clin Risk Manag.</i> 2016; <b>12</b>: 339–50. <a target=xrefwindow id=d8895e1952 href="http://www.ncbi.nlm.nih.gov/pubmed/27042079">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1955 href="http://dx.doi.org/10.2147/TCRM.S85099">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1958 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4780395">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d8895e1967 class=n-a></a>Smith MD, Martin KA, Calabresi PA, <i> et al.</i>: Dimethyl fumarate alters B-cell memory and cytokine production in MS patients. <i>Ann Clin Transl Neurol.</i> 2017; <b>4</b>(5): 351–5. <a target=xrefwindow id=d8895e1978 href="http://www.ncbi.nlm.nih.gov/pubmed/28491903">PubMed Abstract </a> | <a target=xrefwindow id=d8895e1981 href="http://dx.doi.org/10.1002/acn3.411">Publisher Full Text </a> | <a target=xrefwindow id=d8895e1985 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5420807">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730254157"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e1994 class=n-a></a>Wang Q, Chuikov S, Taitano S, <i> et al.</i>: Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway. <i>Int J Mol Sci.</i> 2015; <b>16</b>(6): 13885–907. <a target=xrefwindow id=d8895e2005 href="http://www.ncbi.nlm.nih.gov/pubmed/26090715">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2008 href="http://dx.doi.org/10.3390/ijms160613885">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2012 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4490529">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730254157">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726232983"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2026 class=n-a></a>Lastres-Becker I, García-Yagüe AJ, Scannevin RH, <i> et al.</i>: Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease. <i>Antioxid Redox Signal.</i> 2016; <b>25</b>(2): 61–77. <a target=xrefwindow id=d8895e2037 href="http://www.ncbi.nlm.nih.gov/pubmed/27009601">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2040 href="http://dx.doi.org/10.1089/ars.2015.6549">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2044 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4943471">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726232983">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729974519"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2057 class=n-a></a>Chaves C, Ganguly R, Ceresia C, <i> et al.</i>: Lymphocyte subtypes in relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate. <i>Mult Scler J Exp Transl Clin.</i> 2017; <b>3</b>(2): 2055217317702933. <a target=xrefwindow id=d8895e2068 href="http://www.ncbi.nlm.nih.gov/pubmed/28607757">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2071 href="http://dx.doi.org/10.1177/2055217317702933">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2075 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5408504">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729974519">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726085382"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2088 class=n-a></a>Michell-Robinson MA, Moore CS, Healy LM, <i> et al.</i>: Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis. <i>Ann Clin Transl Neurol.</i> 2016; <b>3</b>(1): 27–41. <a target=xrefwindow id=d8895e2099 href="http://www.ncbi.nlm.nih.gov/pubmed/26783548">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2102 href="http://dx.doi.org/10.1002/acn3.270">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2106 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4704479">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726085382">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727288964"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2119 class=n-a></a>Brennan MS, Matos MF, Richter KE, <i> et al.</i>: The NRF2 transcriptional target, <i>OSGIN1</i>, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes. <i>Sci Rep.</i> 2017; <b>7</b>: 42054. <a target=xrefwindow id=d8895e2133 href="http://www.ncbi.nlm.nih.gov/pubmed/28181536">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2137 href="http://dx.doi.org/10.1038/srep42054">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2140 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5299414">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727288964">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726841262"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2153 class=n-a></a>Lin R, Cai J, Kostuk EW, <i> et al.</i>: Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats. <i>J Neuroinflammation.</i> 2016; <b>13</b>(1): 269. <a target=xrefwindow id=d8895e2164 href="http://www.ncbi.nlm.nih.gov/pubmed/27733178">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2167 href="http://dx.doi.org/10.1186/s12974-016-0733-1">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2171 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5062839">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726841262">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725398947"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2184 class=n-a></a>Brennan MS, Matos MF, Li B, <i> et al.</i>: Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion <i>in vitro</i>. <i>PLoS One.</i> 2015; <b>10</b>(3): e0120254. <a target=xrefwindow id=d8895e2198 href="http://www.ncbi.nlm.nih.gov/pubmed/25793262">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2202 href="http://dx.doi.org/10.1371/journal.pone.0120254">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2205 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4368598">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725398947">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d8895e2219 class=n-a></a>Fumaderm Summary of Product Characteristics. Biogen Idec. 2009. </span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726410695"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2228 class=n-a></a>Ahuja M, Ammal Kaidery N, Yang L, <i> et al.</i>: Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. <i>J Neurosci.</i> 2016; <b>36</b>(23): 6332–51. <a target=xrefwindow id=d8895e2239 href="http://www.ncbi.nlm.nih.gov/pubmed/27277809">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2242 href="http://dx.doi.org/10.1523/JNEUROSCI.0426-16.2016">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2246 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4899530">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726410695">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732114406"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2259 class=n-a></a>Yao Y, Miao W, Liu Z, <i> et al.</i>: Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice. <i>Transl Stroke Res.</i> 2016; <b>7</b>(6): 535–47. <a target=xrefwindow id=d8895e2270 href="http://www.ncbi.nlm.nih.gov/pubmed/27614618">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2273 href="http://dx.doi.org/10.1007/s12975-016-0496-0">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2277 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5065588">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732114406">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726738020"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2290 class=n-a></a>Blewett MM, Xie J, Zaro BW, <i> et al.</i>: Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells. <i>Sci Signal.</i> 2016; <b>9</b>(445): rs10. <a target=xrefwindow id=d8895e2301 href="http://www.ncbi.nlm.nih.gov/pubmed/27625306">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2304 href="http://dx.doi.org/10.1126/scisignal.aaf7694">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2308 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5068918">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726738020">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728390915"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2321 class=n-a></a>Offermanns S, Schwaninger M: Nutritional or pharmacological activation of HCA(2) ameliorates neuroinflammation. <i>Trends Mol Med.</i> 2015; <b>21</b>(4): 245–55. <a target=xrefwindow id=d8895e2329 href="http://www.ncbi.nlm.nih.gov/pubmed/25766751">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2332 href="http://dx.doi.org/10.1016/j.molmed.2015.02.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728390915">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d8895e2345 class=n-a></a>Chen H, Assmann JC, Krenz A, <i> et al.</i>: Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. <i>J Clin Invest.</i> 2014; <b>124</b>(5): 2188–92. <a target=xrefwindow id=d8895e2356 href="http://www.ncbi.nlm.nih.gov/pubmed/24691444">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2359 href="http://dx.doi.org/10.1172/JCI72151">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2363 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4001545">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d8895e2373 class=n-a></a>Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, <i> et al.</i>: Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(17): 4777–82. <a target=xrefwindow id=d8895e2384 href="http://www.ncbi.nlm.nih.gov/pubmed/27078105">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2387 href="http://dx.doi.org/10.1073/pnas.1603907113">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2391 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4855599">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d8895e2400 class=n-a></a>Newman JC, Verdin E: Ketone bodies as signaling metabolites. <i>Trends Endocrinol Metab.</i> 2014; <b>25</b>(1): 42–52. <a target=xrefwindow id=d8895e2408 href="http://www.ncbi.nlm.nih.gov/pubmed/24140022">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2411 href="http://dx.doi.org/10.1016/j.tem.2013.09.002">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2414 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4176946">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d8895e2423 class=n-a></a>Newman JC, Verdin E: β-hydroxybutyrate: much more than a metabolite. <i>Diabetes Res Clin Pract.</i> 2014; <b>106</b>(2): 173–81. <a target=xrefwindow id=d8895e2431 href="http://www.ncbi.nlm.nih.gov/pubmed/25193333">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2434 href="http://dx.doi.org/10.1016/j.diabres.2014.08.009">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2437 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4414487">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d8895e2446 class=n-a></a>Satoh T, McKercher SR, Lipton SA: Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. <i>Free Radic Biol Med.</i> 2013; <b>65</b>: 645–57. <a target=xrefwindow id=d8895e2454 href="http://www.ncbi.nlm.nih.gov/pubmed/23892355">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2457 href="http://dx.doi.org/10.1016/j.freeradbiomed.2013.07.022">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2460 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3859717">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d8895e2469 class=n-a></a>Nagar S, Noveral SM, Trudler D, <i> et al.</i>: MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress. <i>Proc Natl Acad Sci U S A.</i> 2017; <b>114</b>(20): E4048–E4056. <a target=xrefwindow id=d8895e2480 href="http://www.ncbi.nlm.nih.gov/pubmed/28461502">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2483 href="http://dx.doi.org/10.1073/pnas.1613067114">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2487 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5441815">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d8895e2496 class=n-a></a>Lipton SA, Rezaie T, Nutter A, <i> et al.</i>: Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models. <i>Cell Death Dis.</i> 2016; <b>7</b>(12): e2499. <a target=xrefwindow id=d8895e2507 href="http://www.ncbi.nlm.nih.gov/pubmed/27906174">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2510 href="http://dx.doi.org/10.1038/cddis.2016.389">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2514 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5261011">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d8895e2524 class=n-a></a>Satoh T, Stalder R, McKercher SR, <i> et al.</i>: Nrf2 and HSF-1 Pathway Activation via Hydroquinone-Based Proelectrophilic Small Molecules is Regulated by Electrochemical Oxidation Potential. <i>ASN Neuro.</i> 2015; <b>7</b>(4): pii: 1759091415593294. <a target=xrefwindow id=d8895e2535 href="http://www.ncbi.nlm.nih.gov/pubmed/26243592">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2538 href="http://dx.doi.org/10.1177/1759091415593294">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2542 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4550314">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d8895e2551 class=n-a></a>Satoh T, Kosaka K, Itoh K, <i> et al.</i>: Carnosic acid, a <i>catechol-type</i> electrophilic compound, protects neurons both <i>in vitro</i> and <i>in vivo</i> through activation of the Keap1/Nrf2 pathway via <i>S</i>-alkylation of targeted cysteines on Keap1. <i>J Neurochem.</i> 2008; <b>104</b>(4): 1116–31. <a target=xrefwindow id=d8895e2575 href="http://www.ncbi.nlm.nih.gov/pubmed/17995931">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2578 href="http://dx.doi.org/10.1111/j.1471-4159.2007.05039.x">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2581 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4566957">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d8895e2590 class=n-a></a>Rezaie T, McKercher SR, Kosaka K, <i> et al.</i>: Protective effect of carnosic acid, a pro-electrophilic compound, in models of oxidative stress and light-induced retinal degeneration. <i>Invest Ophthalmol Vis Sci.</i> 2012; <b>53</b>(12): 7847–54. <a target=xrefwindow id=d8895e2601 href="http://www.ncbi.nlm.nih.gov/pubmed/23081978">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2604 href="http://dx.doi.org/10.1167/iovs.12-10793">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2608 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3508754">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d8895e2617 class=n-a></a>Shimizu H, Koyama T, Yamada S, <i> et al.</i>: Zonarol, a sesquiterpene from the brown algae <i>Dictyopteris undulata</i>, provides neuroprotection by activating the Nrf2/ARE pathway. <i>Biochem Biophys Res Commun.</i> 2015; <b>457</b>(4): 718–22. <a target=xrefwindow id=d8895e2631 href="http://www.ncbi.nlm.nih.gov/pubmed/25623531">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2635 href="http://dx.doi.org/10.1016/j.bbrc.2015.01.059">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2638 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4577281">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d8895e2647 class=n-a></a>Yamada S, Koyama T, Noguchi H, <i> et al.</i>: Marine hydroquinone zonarol prevents inflammation and apoptosis in dextran sulfate sodium-induced mice ulcerative colitis. <i>PLoS One.</i> 2014; <b>9</b>(11): e113509. <a target=xrefwindow id=d8895e2658 href="http://www.ncbi.nlm.nih.gov/pubmed/25409433">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2661 href="http://dx.doi.org/10.1371/journal.pone.0113509">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2665 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4237432">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d8895e2674 class=n-a></a>Satoh T, Rezaie T, Seki M, <i> et al.</i>: Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes. <i>J Neurochem.</i> 2011; <b>119</b>(3): 569–78. <a target=xrefwindow id=d8895e2685 href="http://www.ncbi.nlm.nih.gov/pubmed/21883218">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2688 href="http://dx.doi.org/10.1111/j.1471-4159.2011.07449.x">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2692 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4580255">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d8895e2702 class=n-a></a>Satoh T, Saitoh S, Hosaka M, <i> et al.</i>: Simple <i>ortho</i>- and <i>para</i>-hydroquinones as compounds neuroprotective against oxidative stress in a manner associated with specific transcriptional activation. <i>Biochem Biophys Res Commun.</i> 2009; <b>379</b>(2): 537–41. <a target=xrefwindow id=d8895e2720 href="http://www.ncbi.nlm.nih.gov/pubmed/19118528">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2723 href="http://dx.doi.org/10.1016/j.bbrc.2008.12.106">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d8895e2732 class=n-a></a>Lipton SA: Pathologically activated therapeutics for neuroprotection. <i>Nat Rev Neurosci.</i> 2007; <b>8</b>(10): 803–8. <a target=xrefwindow id=d8895e2740 href="http://www.ncbi.nlm.nih.gov/pubmed/17882256">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2743 href="http://dx.doi.org/10.1038/nrn2229">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d8895e2752 class=n-a></a>Lipton SA: Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. <i>Curr Drug Targets.</i> 2007; <b>8</b>(5): 621–32. <a target=xrefwindow id=d8895e2760 href="http://www.ncbi.nlm.nih.gov/pubmed/17504105">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2763 href="http://dx.doi.org/10.2174/138945007780618472">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d8895e2772 class=n-a></a>Steel R, Cowan J, Payerne E, <i> et al.</i>: Anti-inflammatory Effect of a Cell-Penetrating Peptide Targeting the Nrf2/Keap1 Interaction. <i>ACS Med Chem Lett.</i> 2012; <b>3</b>(5): 407–10. <a target=xrefwindow id=d8895e2783 href="http://www.ncbi.nlm.nih.gov/pubmed/22582137">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2786 href="http://dx.doi.org/10.1021/ml300041g">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2790 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3350226">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725914956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2799 class=n-a></a>Tu J, Zhang X, Zhu Y, <i> et al.</i>: Cell-Permeable Peptide Targeting the Nrf2-Keap1 Interaction: A Potential Novel Therapy for Global Cerebral Ischemia. <i>J Neurosci.</i> 2015; <b>35</b>(44): 14727–39. <a target=xrefwindow id=d8895e2810 href="http://www.ncbi.nlm.nih.gov/pubmed/26538645">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2813 href="http://dx.doi.org/10.1523/JNEUROSCI.1304-15.2015">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2817 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4635127">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725914956">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727287898"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2830 class=n-a></a>Gazaryan IG, Thomas B: The status of Nrf2-based therapeutics: current perspectives and future prospects. <i>Neural Regen Res.</i> 2016; <b>11</b>(11): 1708–11. <a target=xrefwindow id=d8895e2838 href="http://www.ncbi.nlm.nih.gov/pubmed/28123399">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2841 href="http://dx.doi.org/10.4103/1673-5374.194706">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2844 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5204211">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727287898">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726815278"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2858 class=n-a></a>Jiang ZY, Lu MC, You QD: Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions. <i>J Med Chem.</i> 2016; <b>59</b>(24): 10837–58. <a target=xrefwindow id=d8895e2866 href="http://www.ncbi.nlm.nih.gov/pubmed/27690435">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2869 href="http://dx.doi.org/10.1021/acs.jmedchem.6b00586">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726815278">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d8895e2882 class=n-a></a>Wang L, Lewis T, Zhang YL, <i> et al.</i>: The identification and characterization of non-reactive inhibitor of Keap1-Nrf2 interaction through HTS using a fluorescence polarization assay. Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): Nat Cent Biotech Inform (US); 2010–2012. <a target=xrefwindow id=d8895e2887 href="https://www.ncbi.nlm.nih.gov/books/NBK47352/">Reference Source</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725946016"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2896 class=n-a></a>Abed DA, Goldstein M, Albanyan H, <i> et al.</i>: Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents. <i>Acta Pharm Sin B.</i> 2015; <b>5</b>(4): 285–99. <a target=xrefwindow id=d8895e2907 href="http://www.ncbi.nlm.nih.gov/pubmed/26579458">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2910 href="http://dx.doi.org/10.1016/j.apsb.2015.05.008">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2914 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4629420">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725946016">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717992184"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2927 class=n-a></a>Hu L, Magesh S, Chen L, <i> et al.</i>: Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction. <i>Bioorg Med Chem Lett.</i> 2013; <b>23</b>(10): 3039–43. <a target=xrefwindow id=d8895e2938 href="http://www.ncbi.nlm.nih.gov/pubmed/23562243">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2941 href="http://dx.doi.org/10.1016/j.bmcl.2013.03.013">Publisher Full Text </a> | <a target=xrefwindow id=d8895e2945 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3648997">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717992184">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d8895e2958 class=n-a></a>Marcotte D, Zeng W, Hus JC, <i> et al.</i>: Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. <i>Bioorg Med Chem.</i> 2013; <b>21</b>(14): 4011–9. <a target=xrefwindow id=d8895e2969 href="http://www.ncbi.nlm.nih.gov/pubmed/23647822">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2972 href="http://dx.doi.org/10.1016/j.bmc.2013.04.019">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726615992"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e2981 class=n-a></a>Quinti L, Casale M, Moniot S, <i> et al.</i>: SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models. <i>Cell Chem Biol.</i> 2016; <b>23</b>(7): 849–61. <a target=xrefwindow id=d8895e2992 href="http://www.ncbi.nlm.nih.gov/pubmed/27427231">PubMed Abstract </a> | <a target=xrefwindow id=d8895e2995 href="http://dx.doi.org/10.1016/j.chembiol.2016.05.015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726615992">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727365229"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e3009 class=n-a></a>Kerr F, Sofola-Adesakin O, Ivanov DK, <i> et al.</i>: Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease. <i>PLoS Genet.</i> 2017; <b>13</b>(3): e1006593. <a target=xrefwindow id=d8895e3020 href="http://www.ncbi.nlm.nih.gov/pubmed/28253260">PubMed Abstract </a> | <a target=xrefwindow id=d8895e3023 href="http://dx.doi.org/10.1371/journal.pgen.1006593">Publisher Full Text </a> | <a target=xrefwindow id=d8895e3027 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5333801">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727365229">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726377123"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e3040 class=n-a></a>Lu MC, Ji JA, Jiang YL, <i> et al.</i>: An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis. <i>Sci Rep.</i> 2016; <b>6</b>: 26585. <a target=xrefwindow id=d8895e3051 href="http://www.ncbi.nlm.nih.gov/pubmed/27215610">PubMed Abstract </a> | <a target=xrefwindow id=d8895e3054 href="http://dx.doi.org/10.1038/srep26585">Publisher Full Text </a> | <a target=xrefwindow id=d8895e3058 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4877580">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726377123">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726271553"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e3071 class=n-a></a>Zhou Y, Wu H, Zhao M, <i> et al.</i>: The Bach Family of Transcription Factors: A Comprehensive Review. <i>Clin Rev Allergy Immunol.</i> 2016; <b>50</b>(3): 345–56. <a target=xrefwindow id=d8895e3082 href="http://www.ncbi.nlm.nih.gov/pubmed/27052415">PubMed Abstract </a> | <a target=xrefwindow id=d8895e3085 href="http://dx.doi.org/10.1007/s12016-016-8538-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726271553">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d8895e3098 class=n-a></a>So AY, Garcia-Flores Y, Minisandram A, <i> et al.</i>: Regulation of APC development, immune response, and autoimmunity by Bach1/HO-1 pathway in mice. <i>Blood.</i> 2012; <b>120</b>(12): 2428–37. <a target=xrefwindow id=d8895e3109 href="http://www.ncbi.nlm.nih.gov/pubmed/22791292">PubMed Abstract </a> | <a target=xrefwindow id=d8895e3112 href="http://dx.doi.org/10.1182/blood-2012-04-426247">Publisher Full Text </a> | <a target=xrefwindow id=d8895e3116 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3448256">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d8895e3125 class=n-a></a>Attucks OC, Jasmer KJ, Hannink M, <i> et al.</i>: Induction of heme oxygenase I (HMOX1) by HPP-4382: a novel modulator of Bach1 activity. <i>PLoS One.</i> 2014; <b>9</b>(7): e101044. <a target=xrefwindow id=d8895e3136 href="http://www.ncbi.nlm.nih.gov/pubmed/25019514">PubMed Abstract </a> | <a target=xrefwindow id=d8895e3139 href="http://dx.doi.org/10.1371/journal.pone.0101044">Publisher Full Text </a> | <a target=xrefwindow id=d8895e3143 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4096395">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d8895e3152 class=n-a></a>Ohta R, Tanaka N, Nakanishi K, <i> et al.</i>: Heme oxygenase-1 modulates degeneration of the intervertebral disc after puncture in Bach 1 deficient mice. <i>Eur Spine J.</i> 2012; <b>21</b>(9): 1748–57. <a target=xrefwindow id=d8895e3163 href="http://www.ncbi.nlm.nih.gov/pubmed/22832873">PubMed Abstract </a> | <a target=xrefwindow id=d8895e3166 href="http://dx.doi.org/10.1007/s00586-012-2442-5">Publisher Full Text </a> | <a target=xrefwindow id=d8895e3170 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3459108">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726273509"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e3180 class=n-a></a>Katsuoka F, Yamamoto M: Small Maf proteins (MafF, MafG, MafK): History, structure and function. <i>Gene.</i> 2016; <b>586</b>(2): 197–205. <a target=xrefwindow id=d8895e3188 href="http://www.ncbi.nlm.nih.gov/pubmed/27058431">PubMed Abstract </a> | <a target=xrefwindow id=d8895e3191 href="http://dx.doi.org/10.1016/j.gene.2016.03.058">Publisher Full Text </a> | <a target=xrefwindow id=d8895e3194 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4911266">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726273509">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727790582"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8895e3207 class=n-a></a>Tsuchiya M, Misaka R, Nitta K, <i> et al.</i>: Transcriptional factors, Mafs and their biological roles. <i>World J Diabetes.</i> 2015; <b>6</b>(1): 175–83. <a target=xrefwindow id=d8895e3218 href="http://www.ncbi.nlm.nih.gov/pubmed/25685288">PubMed Abstract </a> | <a target=xrefwindow id=d8895e3221 href="http://dx.doi.org/10.4239/wjd.v6.i1.175">Publisher Full Text </a> | <a target=xrefwindow id=d8895e3225 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4317310">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727790582">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d8895e3238 class=n-a></a>Davudian S, Mansoori B, Shajari N, <i> et al.</i>: BACH1, the master regulator gene: A novel candidate target for cancer therapy. <i>Gene.</i> 2016; <b>588</b>(1): 30–7. <a target=xrefwindow id=d8895e3249 href="http://www.ncbi.nlm.nih.gov/pubmed/27108804">PubMed Abstract </a> | <a target=xrefwindow id=d8895e3252 href="http://dx.doi.org/10.1016/j.gene.2016.04.040">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 14 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2138/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2138/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Anti-Aging Food Research, School of Bioscience and Biotechnology, Tokyo University of Technology, Tokyo, Japan<br/> <sup>2</sup> Neuroscience Translational Center and Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA<br/> <sup>3</sup> Neurodegenerative Disease Center, Scintillon Institute, San Diego, CA, USA<br/> <sup>4</sup> Department of Neurosciences, University of California, School of Medicine, La Jolla, CA, USA<br/> <p> <div class=margin-bottom> Takumi Satoh <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Review & Editing </div> <div class=margin-bottom> Stuart Lipton <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Original Draft Preparation </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2138/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 14 Dec 2017, 6:2138 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12111.1">https://doi.org/10.12688/f1000research.12111.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Satoh T and Lipton S. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13106 data-id=12111 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12111.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2138/v1/pdf?article_uuid=032db233-2803-4411-b21d-2a140b03fb31" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12111.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Satoh T and Lipton S. Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2138 (<a href="https://doi.org/10.12688/f1000research.12111.1" target=_blank>https://doi.org/10.12688/f1000research.12111.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12111 id=mobile-track-article-signin-12111 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12111?target=/articles/6-2138/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13106 /> <input name=articleId type=hidden value=12111 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Taixing Cui</strong>, Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Lu Cai</strong>, Department of Pediatrics, Pediatric Research Institute, Wendy L. Novak Diabetes Care Center, University of Louisville, USA; Chinese-American Research Institute for Diabetic Complications, School of Pharmaceutical Science, Wenzhou Medical University, China </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Xinyue Hu</strong>, Center of Cardiovascular Diseases, The First Hospital of Jilin University, China </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 14 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2138/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2138/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28156-28103></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28157-28104></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2138/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>14 Dec 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Taixing Cui</strong>, Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Lu Cai</strong>, Department of Pediatrics, Pediatric Research Institute, Wendy L. Novak Diabetes Care Center, University of Louisville, USA; Chinese-American Research Institute for Diabetic Complications, School of Pharmaceutical Science, Wenzhou Medical University, China </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Xinyue Hu</strong>, Center of Cardiovascular Diseases, The First Hospital of Jilin University, China </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2138/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2138/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding NRF2 as...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2138/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2138/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2138/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Satoh T and Lipton S');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2138/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2138",
            templates : {
                twitter : "Recent advances in understanding NRF2 as a druggable target:.... Satoh T and Lipton S, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2138/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12111/13106")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13106");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "28103": 0,
                           "28104": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "548bf21c-512b-4258-944e-e5b71d5e32a9";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2138.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2138.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2138.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2138.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2138.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>